Healthcare -
Biotechnology - NASDAQ - US
$ 684.01
0.136 %
$ 73.9 B
Market Cap
16.93
P/E
REGN - CASH & EQUIVALENTS
Cash & Equivalents REGN - Regeneron Pharmaceuticals, Inc.
2.73 B
LAST VALUE
-2.73%
2 YEAR CAGR
13.22%
5 YEAR CAGR
17.69%
10 YEAR CAGR